Filter
327
Filtered Results: 327
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
44
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
10
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
6
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
21
Public Health
8
Key Resources
8
Women & Child Health
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
COVID-19
206
Refugee
22
HIV
9
TB
9
Rapid Response
6
Mental Health
6
NTDs
5
Conflict
5
Ebola & Marburg
4
Pharmacy
3
Health Financing Toolbox
3
NCDs
2
Specific Hazards
1
Planetary Health
1
Zika
1
Global Health Education
1
AMR
1
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Vaccine hesitancy
recommended
April 19,2021
MEDBOX Issue Brief no.12
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
Available in different languages
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
12 February 2021
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
September 2021
– векторною вакциною – (Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson)
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit Vektor-Impfstoff – (COVID-19 Vacc...
